Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumor × olaparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 23 Breast Neoplasms 21 Fallopian Tube Neoplasms 13 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 8 Neoplasms 6 Endometrial Neoplasms 6 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Stomach Neoplasms 3 Lymphoma, Non-Hodgkin 3 Glioma 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Glioblastoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1

Interventions

Injections 3 zimberelimab 1 tumor-cells apoptosis factor, human 1 toripalimab 1 tislelizumab 1 tazemetostat 1 pembrolizumab 1 cemiplimab 1 cedazuridine 1 WW Domain-Containing Oxidoreductase 1 Specimen Handling 1 RE1-silencing transcription factor 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Indocyanine Green 1 Fluorodeoxyglucose F18 1 Doxorubicin 1 Decitabine 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Blood Specimen Collection 1 Blood Component Removal 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡